je.st
news
Label changed on Biogen's top MS drug to reflect patient death
2014-11-25 22:03:21| Biotech - Topix.net
Biogen's Tecfidera was the biggest locally developed drug to be approved in the U.S. in 2013. It's expected to make more than $4 billion in revenue in 2018.
Tags: top
death
changed
drug
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||